BSTG Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Jul 2023 @ 15:14):

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways...

Stats
Today's Volume	4 533.00
Average Volume	972.00
Market Cap	57.82M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.20
ATR14	$0.130 (3.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-11	He Junli	Buy	220 640	Stock Option (right to buy)
2023-12-27	He Junli	Buy	2 700	Common Stock
2023-12-14	He Junli	Buy	900	Common Stock
2023-12-06	He Junli	Buy	1 500	Common Stock
2023-09-11	He Junli	Buy	1 500	Common Stock

INSIDER POWER
78.09
Last 94 transactions
Buy: 5 930 750 \| Sell: 1 021 989

Volume Correlation

Long: 0.03 (neutral)

Short: 0.00 (neutral)

Signal:(37.812) Neutral

Biostage, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biostage, Inc. Correlation - Currency/Commodity

-0.43
( neutral )

-0.36
( neutral )

-0.73
( moderate negative )

0.87
( strong )

0.01
( neutral )

0.10
( neutral )

Biostage, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-1.090

Q3	2023
Revenue:	$0
Gross Profit:	$-13 000.00 (0.00 %)
EPS:	$-0.120

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.190

Q1	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.240

Financial Reports:

No articles found.

Biostage, Inc.

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.